Nitrous oxide

Description

Nitrous oxide is a non-flammable gas classified as a United States Pharmacopeia (USP) substance. Its Chemical Abstracts Service (CAS) number is 10024-97-2.

Uses and Indications

This drug is indicated for use in medical settings where Nitrous Oxide is deemed appropriate for analgesia or sedation. Administration of Nitrous Oxide may be hazardous or contraindicated; therefore, it is to be used only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrous Oxide. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of Use: There are no specific teratogenic or nonteratogenic effects associated with this drug mentioned in the available data. However, practitioners should exercise caution and adhere to established guidelines when considering its use in various patient populations.

Dosage and Administration

Administration of nitrous oxide is conducted via the respiratory route through inhalation. The active ingredient is provided in a concentration of 990 mL in 1 L.

It is imperative that the administration of nitrous oxide is performed by or under the supervision of a licensed practitioner who possesses experience in the use and administration of this agent. This ensures the safety and efficacy of the treatment, adhering to established medical standards and protocols.

Contraindications

Administration of Nitrous Oxide is contraindicated in situations where safety precautions have not been fully understood and implemented. It should only be administered by or under the supervision of a licensed practitioner experienced in its use, who is knowledgeable about its indications, effects, dosages, methods, frequency, duration of administration, hazards, contraindications, side effects, and necessary precautions.

Additionally, the following precautions must be observed:

• Avoid breathing the gas directly.

• Do not allow contact with eyes, skin, or clothing.

Failure to adhere to these guidelines may result in hazardous situations.

Warnings and Precautions

Administration of Nitrous Oxide may pose significant risks and is contraindicated in certain situations. It is imperative that this agent be used solely by or under the supervision of a licensed practitioner who possesses expertise in the administration of Nitrous Oxide. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Hazardous Properties Nitrous Oxide is classified as an oxidizer and contains gas under pressure, which may lead to explosive conditions if exposed to heat. It is crucial to recognize that this substance may cause or intensify fire. Additionally, exposure to Nitrous Oxide can result in drowsiness or dizziness, and it has the potential to displace oxygen, leading to rapid suffocation. Frostbite may also occur upon contact with the gas.

Safety Precautions Prior to handling Nitrous Oxide, all safety precautions must be thoroughly read and understood. It should be stored away from clothing and other combustible materials, and care must be taken to keep valves and fittings free from grease and oil. Users should avoid inhaling the gas and prevent contact with eyes, skin, or clothing. Nitrous Oxide should only be used and stored outdoors or in well-ventilated areas. In the event of a fire, efforts should be made to stop the leak if it is safe to do so. A backflow preventive device should be utilized in the piping, and only equipment made from compatible materials and rated for cylinder pressure should be employed. Equipment must also be cleaned for oxygen service. Valves should be opened slowly and closed after each use or when empty. Protection from sunlight is necessary when ambient temperatures exceed 52 degrees Celsius (125 degrees Fahrenheit). It is essential to read and follow the Safety Data Sheet (SDS) prior to use.

First Aid Measures In the event of inhalation, the affected individual should be removed to fresh air and kept comfortable for breathing. If the person feels unwell, it is critical to contact a poison center or a physician. For skin exposure, any frostbite should be treated by thawing the affected areas with lukewarm water; rubbing the area is contraindicated. Immediate medical advice or attention should be sought in such cases.

Emergency Medical Assistance If any adverse effects are experienced, including those related to inhalation or skin contact, it is vital to call a poison center or a healthcare professional for further guidance.

Side Effects

Patients using nitrous oxide may experience a range of adverse reactions, which can vary in seriousness and frequency.

Serious adverse reactions include the potential for drowsiness or dizziness, which may impair the ability to perform tasks requiring alertness. Additionally, nitrous oxide is an oxidizer that can intensify fire hazards; therefore, it is crucial to handle it with care to prevent explosions, especially when heated. The gas is also capable of displacing oxygen, leading to rapid suffocation, which poses a significant risk in enclosed spaces. Frostbite is another serious concern, particularly if the gas comes into contact with the skin.

In the event of inhalation, it is recommended to remove the affected individual to fresh air and ensure they are comfortable while breathing. If the individual feels unwell, it is imperative to contact a poison center or a healthcare professional for further assistance. For those who experience skin contact, it is advised to thaw any frostbitten areas with lukewarm water without rubbing the affected skin, and to seek immediate medical advice or attention.

These adverse reactions highlight the importance of proper handling and awareness of the risks associated with nitrous oxide use.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric use of Nitrous Oxide is not specifically detailed in the available prescribing information. There are no recommended age ranges, dosing differences, safety concerns, or special precautions for pediatric patients mentioned in the insert. Therefore, healthcare professionals should exercise caution and consider the lack of specific data when administering Nitrous Oxide to children.

Geriatric Use

Elderly patients do not have specific geriatric use considerations, dosage adjustments, safety concerns, or special precautions outlined in the provided information. Therefore, healthcare providers may not need to implement any additional measures when prescribing this medication to geriatric patients. However, standard clinical judgment should always be exercised when treating elderly individuals, taking into account their overall health status and any concomitant medications.

Pregnancy

The administration of Nitrous Oxide during pregnancy may pose potential risks to the fetus and is considered hazardous or contraindicated. Healthcare professionals should exercise caution when considering the use of Nitrous Oxide in pregnant patients due to the associated concerns regarding fetal outcomes. It is essential to evaluate the benefits and risks carefully before administering this agent to women of childbearing potential.

Lactation

There are no specific warnings or recommendations regarding the use of Nitrous Oxide in lactating mothers. Additionally, there are no specific warnings or recommendations concerning the use of Nitrous Oxide during lactation. As such, healthcare professionals may consider the absence of contraindications when advising lactating mothers on the use of this agent.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function provided in the insert for Nitrous Oxide. Healthcare professionals should exercise caution and consider the lack of data when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of Nitrous Oxide. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for this patient population. It is recommended that healthcare providers exercise caution and consider the overall clinical context when administering Nitrous Oxide to patients with compromised liver function.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, altered mental status, cardiovascular instability, or gastrointestinal disturbances.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage data is not available, healthcare professionals should exercise caution and be prepared to act swiftly in the event of an overdose, ensuring that appropriate measures are taken to safeguard patient health.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: drowsiness, dizziness, and frostbite. These events have been documented in the context of routine pharmacovigilance activities.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrous Oxide may be hazardous or contraindicated and is intended for use only by or under the supervision of a licensed practitioner experienced in its use. It is essential that the practitioner is familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be made aware of the potential dangers associated with Nitrous Oxide, including its ability to cause or intensify fire, as it is an oxidizer that contains gas under pressure and may explode if heated. They should also be informed that the gas may cause drowsiness or dizziness, and that it can displace oxygen, leading to rapid suffocation. Additionally, patients should be cautioned about the risk of frostbite.

It is crucial for patients to understand the importance of reading and comprehending all safety precautions before handling Nitrous Oxide. They should be instructed to keep and store the gas away from clothing and other combustible materials, ensuring that valves and fittings remain free from grease and oil. Patients should avoid breathing the gas and should not allow it to come into contact with their eyes, skin, or clothing.

Healthcare providers should emphasize that Nitrous Oxide should only be used and stored outdoors or in a well-ventilated area. In the event of a fire, patients should be advised to stop the leak if it is safe to do so. They should also be informed about the necessity of using a backflow preventive device in the piping and only utilizing equipment made of compatible materials rated for cylinder pressure and cleaned for oxygen service.

Patients should be instructed to open the valve slowly and to close it after each use and when the cylinder is empty. They should be made aware of the need to protect the gas from sunlight when the ambient temperature exceeds 52 degrees C (125 degrees F).

In case of an emergency, healthcare providers should inform patients of the first aid measures to take if Nitrous Oxide is inhaled, which include removing the person to fresh air and keeping them comfortable for breathing, as well as calling a poison center or physician if they feel unwell. If the gas comes into contact with the skin, patients should be advised to thaw any frosted areas with lukewarm water without rubbing the affected area and to seek immediate medical advice or attention.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product away from clothing and other combustible materials to prevent fire hazards. Valves and fittings must be kept free from grease and oil to ensure safe operation.

This product should only be used and stored outdoors or in a well-ventilated area. When the ambient temperature exceeds 52 degrees Celsius (125 degrees Fahrenheit), it is crucial to protect the product from direct sunlight. Users are advised to open the valve slowly and to close it securely after each use and when the product is empty.

To maintain safety, a backflow preventive device should be utilized in the piping system. The product must only be used with equipment that is constructed from compatible materials and rated for cylinder pressure. Additionally, it is imperative to use the product solely with equipment that has been cleaned for oxygen service. Prior to handling, all safety precautions must be thoroughly read and understood to ensure safe usage.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. Clinicians should counsel patients that the administration of Nitrous Oxide may pose hazards or be contraindicated. It is essential that this medication is used only by or under the supervision of a licensed practitioner who has experience with Nitrous Oxide. This practitioner should be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by Oxarc, LLC. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)